Event Date/Time: Jun 07, 2013 / 7:30 am - (EST) End Date/Time: Jun 08, 2013 / 5:00 pm - (EST)
Report as Spam


NOTE: This is a one day course. You choose what day to attend. The program is the same each day. The FDA approved an innovative three-dimensional digital mammography system in February 2011 that shows measurable improvement in clinical performance over conventional two-dimensional mammography. This new technology, called breast Tomosynthesis, is expected to detect more cancers while resulting in fewer unnecessary diagnostic imaging studies and procedures. The FDA mandated that radiologists wishing to use the technology receive eight hours of case-based training in Tomosynthesis interpretation.   The workshop, presented by World Class CME, features an eight-hour comprehensive training program in breast Tomosynthesis. Participants will have the opportunity to sit at clinical workstations and review over 100 clinical Tomosynthesis data sets with accompanying standard mammography while being guided by expert faculty, Drs. Elizabeth Rafferty and Phoebe Freer, in Tomosynthesis interpretation. The course will not only fulfill the FDA training requirement, but will also provide a unique opportunity to assess the potential impact Tomosynthesis could have for a physician’s practice while receiving individual instruction.


35 Crosby Dr., Ste 302
United States

Conference Speakers

Elizabeth A. Rafferty, MD Director of Breast Imaging Avon Comprehensive Breast Center Massachusetts General Hospital Boston, Massachusetts

Phoebe Freer, MD

Avon Comprehensive Breast Center Massachusetts General Hospital Boston, Massachusetts